Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention (X-PLORER)

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: August 18, 2011
Last updated: January 7, 2015
Last verified: January 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)